Yichao Han

197 Ruijin 2nd Road
Shanghai, 200025, China

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 32 publications

Author Correction: Targeting MondoA-TXNIP restores antitumour immunity in lactic-acid-induced immunosuppressive microenvironment.

Author Correction: Targeting MondoA-TXNIP restores antitumour immunity in lactic-acid-induced immunosuppressive microenvironment.

Journal: Nature metabolism
Published: September 03, 2026

Tumor-intrinsic NSUN2 orchestrates immunosuppression in lung adenocarcinoma via the m5C-HDAC8-CCL5 axis.

Tumor-intrinsic NSUN2 orchestrates immunosuppression in lung adenocarcinoma via the m5C-HDAC8-CCL5 axis.

Journal: Experimental hematology & oncology
Published: March 27, 2026

Targeting the FOXP3-T-bet interaction to restore Treg stability in IFN-γ-driven autoimmunity.

Targeting the FOXP3-T-bet interaction to restore Treg stability in IFN-γ-driven autoimmunity.

Journal: Cellular & molecular immunology
Published: February 01, 2026

Conversion Surgery After Induction Therapy for Initially Unresectable Stage III Non-small Cell Lung Cancer: A Proof-of-Concept Trial.

Conversion Surgery After Induction Therapy for Initially Unresectable Stage III Non-small Cell Lung Cancer: A Proof-of-Concept Trial.

Journal: Annals of surgical oncology
Published: November 05, 2025

Preoperative pembrolizumab (anti-PD-1 antibody) combined with chemoradiotherapy for esophageal squamous cell carcinoma: a phase 1/2 trial (PALACE-2).

Preoperative pembrolizumab (anti-PD-1 antibody) combined with chemoradiotherapy for esophageal squamous cell carcinoma: a phase 1/2 trial (PALACE-2).

Journal: Signal transduction and targeted therapy
Published: May 29, 2025

Robot-assisted anatomical lung resection with a modular robotic system: Preliminary experience from a single-arm, prospective trial.

Robot-assisted anatomical lung resection with a modular robotic system: Preliminary experience from a single-arm, prospective trial.

Journal: JTCVS techniques
Published: May 16, 2025

Integrative analysis reveals prognostic value of cuproptosis and copper hemostasis related genes in immunotherapy for non-small cell lung cancer.

Integrative analysis reveals prognostic value of cuproptosis and copper hemostasis related genes in immunotherapy for non-small cell lung cancer.

Journal: NPJ precision oncology
Published: March 23, 2025

TROAP promotes esophageal squamous cell carcinoma progression via the PI3K/AKT pathway.

TROAP promotes esophageal squamous cell carcinoma progression via the PI3K/AKT pathway.

Journal: Journal of cancer research and clinical oncology
Published: March 19, 2025

Targeting MondoA-TXNIP restores antitumour immunity in lactic-acid-induced immunosuppressive microenvironment.

Targeting MondoA-TXNIP restores antitumour immunity in lactic-acid-induced immunosuppressive microenvironment.

Journal: Nature metabolism
Published: October 03, 2024

Robotic-assisted versus video-assisted lobectomy for resectable non-small-cell lung cancer: the RVlob randomized controlled trial.

Robotic-assisted versus video-assisted lobectomy for resectable non-small-cell lung cancer: the RVlob randomized controlled trial.

Journal: EClinicalMedicine
Published: March 20, 2024

High-dimensional single-cell proteomics analysis of esophageal squamous cell carcinoma reveals dynamic alterations of the tumor immune microenvironment after neoadjuvant therapy.

High-dimensional single-cell proteomics analysis of esophageal squamous cell carcinoma reveals dynamic alterations of the tumor immune microenvironment after neoadjuvant therapy.

Journal: Journal for immunotherapy of cancer
Published: November 06, 2023

Immune microenvironment heterogeneity of concurrent adenocarcinoma and squamous cell carcinoma in multiple primary lung cancers.

Immune microenvironment heterogeneity of concurrent adenocarcinoma and squamous cell carcinoma in multiple primary lung cancers.

Journal: NPJ precision oncology
Published: June 17, 2023
Showing 1-12 of 32

Last Updated: 09/26/2026